Get started
Author

Barbara Körber-Irrgang

Observed names: B. KÖRBER‐IRRGANG, B. Körber-Irrgang, Barbara Korber-Irrgang, Körber-Irrgang, B., Körber-Irrgang, Barbara
ORCID: 0009-0002-9588-965X
Observed ORCID: 0009-0002-9588-965X
OpenAlex ID: A5008896502
Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005–2009)
2012 · X. Schleicher, P.G. Higgins, et al. · Clinical Microbiology and Infection · 85
PDF
In Vitro Spectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
2011 · Will Stubbings, Pamela Leow, et al. · Antimicrobial Agents and Chemotherapy · 72
In Vitro Activity of Nitroxoline against Escherichia coli Urine Isolates from Outpatient Departments in Germany
2014 · Michael Kresken, Barbara Körber-Irrgang · Antimicrobial Agents and Chemotherapy · 62
Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries
2015 · M. Kresken, B. Körber-Irrgang, et al. · Clinical Microbiology and Infection · 61
PDF
Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: Extended-spectrum β-lactamases and the role of fosfomycin
2014 · Michael Kresken, Yvonne Pfeifer, et al. · International Journal of Antimicrobial Agents · 48
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany
2020 · Michael Kresken, Barbara Körber-Irrgang, et al. · International Journal of Antimicrobial Agents · 36
Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany
2011 · Study Group, M. Kresken, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 32
In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany
2017 · Harald Seifert, Barbara Körber-Irrgang, et al. · International Journal of Antimicrobial Agents · 30
The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem‐resistant Acinetobacter baumannii isolates in Germany, 2010‐2019
2022 · Esther Wohlfarth, Michael Kresken, et al. · International Journal of Antimicrobial Agents · 25
Antimicrobial susceptibility of bacterial isolates from patients presenting with ear, nose and throat (ENT) infections in the German community healthcare setting
2017 · Working Party ‘Antimicrobial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy, B. Olzowy, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 24
Eradication of Methicillin-Resistant Staphylococcus aureus and of Enterobacteriaceae Expressing Extended-Spectrum Beta-Lactamases on a Model Pig Farm
2015 · Ricarda Maria Schmithausen, Sophia Ricarda Kellner, et al. · Applied and Environmental Microbiology · 23
PDF
Phenotypic Detection and Differentiation of Carbapenemase Classes Including OXA-48-Like Enzymes in Enterobacterales and Pseudomonas aeruginosa by a Highly Specialized Micronaut-S Microdilution Assay
2020 · Niels Pfennigwerth, Sören G. Gatermann, et al. · Journal of Clinical Microbiology · 22
In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time–kill methodology
2011 · Michael Kresken, Barbara Körber-Irrgang, et al. · International Journal of Antimicrobial Agents · 22
Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam
2018 · Michael Kresken, Barbara Körber-Irrgang · Journal of Clinical Microbiology · 18
PDF
Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany
2014 · Nicole Nari Horn, Michael Kresken, et al. · International Journal of Medical Microbiology · 17
Performance evaluation of the Specific Reveal system for rapid antibiotic susceptibility testing from positive blood cultures containing Gram-negative pathogens
2024 · Greta Ostermann, Barbara Körber-Irrgang, et al. · Journal of Clinical Microbiology · 15
Activity of temocillin against CTX-M-producing Escherichia coli and Klebsiella pneumoniae from Germany
2017 · Michael Kresken, Barbara Körber-Irrgang, et al. · International Journal of Antimicrobial Agents · 14
Rapid high-throughput processing of tissue samples for microbiological diagnosis of periprosthetic joint infections using bead-beating homogenization
2024 · Nathalie Jazmati, Carolin Liebold, et al. · Journal of Clinical Microbiology · 8
PDF
Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006–2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST)
2016 · Kresken, Michael, Körber-Irrgang, Barbara, et al. · PubMed Central · 8
PDF
Comparative activity of pradofloxacin and marbofloxacin against coagulase‐positive staphylococci in a pharmacokinetic–pharmacodynamic model based on canine pharmacokinetics
2012 · B. KÖRBER‐IRRGANG, H.‐G. WETZSTEIN, et al. · Journal of Veterinary Pharmacology and Therapeutics · 8
Rapid Antimicrobial Susceptibility Testing Using the MicroScan System: Performance Evaluation of a 4-Hour Bacterial Cultivation From Positive Blood Cultures
2024 · Alexander Krüger, Barbara Körber-Irrgang, et al. · Current Microbiology · 4
Escherichia coli ST1421 harbouring the hybrid extended-spectrum β-lactamase CTX-M-64 from a German patient
2018 · Yvonne Pfeifer, Guido Werner, et al. · Journal of Global Antimicrobial Resistance · 4
In-vitro-Aktivität von Mecillinam gegen Escherichia coli: Urinisolate von Patienten im niedergelassenen Versorgungsbereich in Deutschland
2017 · Michael Kresken, Barbara Körber-Irrgang, et al. · Aktuelle Urologie · 4
Effect of novel antimicrobial blue light-emitting optical fiber on vancomycin-resistant Enterococcus faecium and carbapenemase-producing Klebsiella pneumoniae
2025 · Megan H. Goh, Barbara Körber-Irrgang, et al. · Journal of Bone and Joint Infection · 3
PDF
In vitro activity of daptomycin combined with other antimicrobial agents against Gram-negative bacteria
2010 · Körber-Irrgang, B., Kresken, M. · German Medical Science (German Research Foundation) · 3
Works count: 46
Citation count: 652
H-index: 15
I10-index: 17
Year
Topic
Type